Reliable pre-eclampsia pathways based on multiple independent microarray data sets

Molecular Human Reproduction

Volumn 21, Issue 2, 2014, Pages 217-224

  Kawasaki, Kaoru ^a   Kondoh, Eiji ^a   Chigusa, Yoshitsugu ^a   Ujita, Mari ^a   Murakami, Ryusuke ^a   Mogami, Haruta ^a   Brown, J B ^a   Okuno, Yasushi ^a   Konishi, Ikuo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Microarray; Pathway; Pre eclampsia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1C; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PREGNANCY; PROCEDURES;

ADULT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84928171193     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gau096     Document Type: Article

References (29)

1. Arngrímsson R, Sigurõardóttir S, Frigge ML, Bjarnadóttir RI, Jónsson T, Stefánsson H, Baldursdóttir A, Einarsdóttir AS, Palsson B, Snorradóttir S et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999;8: 1799-1805.
2. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009;462: 108-112.
3. Berntsen HF, Wigestrand MB, Bogen IL, Fonnum F, Walaas SI, Moldes-Anaya A. Mechanisms of penitrem-induced cerebellar granule neuron death in vitro: possible involvement of GABAA receptors and oxidative processes. Neurotoxicology 2013;35:129-136.
4. Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P, Robinson WP. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod 2013;19:697-708.
5. Chigusa Y, Tatsumi K, Kondoh E, Fujita K, Nishimura F, Mogami H, Konishi I. Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia. J Clin Endocrinol Metab 2012;97:E1862-E1870.
6. Chigusa Y, Kondoh E, Mogami H, Nishimura F, Ujita M, Kawasaki K, Fujita K, Tatsumi K, Konishi I. ATP-binding cassette transporter A1 expression is decreased in preeclamptic placentas. Reprod Sci 2013;20:891-898.
7. Gardner LB, Hori T, Chen F, Baine AM, Hata T, Uemoto S, Nguyen JH. Effect of specific activation of g-aminobutyric acid receptor in vivoon oxidative stress-induced damage after extended hepatectomy. Hepatol Res 2012;42:1131-1140.
8. Gatza ML, Lucas JE, BarryWT, Kim JW,Wang Q, Crawford MD, Datto MB, Kelley M, Mathey-Prevot B, Potti A et al. A pathway-based classification of human breast cancer. Proc Natl Acad Sci USA 2010;107:6994-6999.
9. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn 2002;46: 389-422.
10. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, Taketani Y. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997;38:89-93.
11. Kanayama N, Takahashi K, MatsuuraT, Sugimura M, KobayashiT, Moniwa N, Tomita M, Nakayama K. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 2002;12:1129-1135.
12. Kruskal JB. Multidimensional scaling by optimizing goodness of fit to a nonmetric hypothesis. Psychometrika1964;29:1.
13. Lachmeijer AM, Arngrímsson R, Bastiaans EJ, Frigge ML, Pals G, Sigurdardóttir S, Stéfansson H, Pálsson B, Nicolae D, Kong A et al. A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet 2001;9:758-764.
14. Laivuori H, Lahermo P, Ollikainen V, Widen E, Häivä-Mällinen L, Sundström H, Laitinen T, Kaaja R, Ylikorkala O, Kere J. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet 2003;72:168-177.
15. Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget 2012;3:759-773.
16. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111: 649-658.
17. Meng T, Chen H, Sun M, Wang H, Zhao G, Wang X. Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. OMICS 2012;16:301-311.
18. Mistry HD, Kurlak LO, Williams PJ, Ramsay MM, Symonds ME, Broughton Pipkin F. Differential expression and distribution of placental glutathione peroxidases 1, 3 and 4 in normal and preeclamptic pregnancy. Placenta 2010;31:401-408.
19. Moslehi R, Mills JL, Signore C, Kumar A, Ambroggio X, Dzutsev A. Integrative transcriptome analysis reveals dysregulation of canonical cancer molecular pathways in placenta leading to preeclampsia. Sci Rep 2013;3:2407.
20. Nevins JR. Pathway-based classification of lung cancer: a strategy to guide therapeutic selection. Proc Am Thorac Soc 2011;8:180-182.
21. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-1594.
22. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004;101:9309-9314.
23. Schçlkopf B, Smola A. Learning with Kernels: Support Vector Machines Regularization, Optimization, and Beyond. Cambridge: MIT Press, 2002.
24. Shawe-Taylor J, Cristianini N. Kernel Methods for Pattern Analysis. Cambridge, UK: Cambridge University Press, 2004.
25. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Va°rtun A, Acharya G. Differential placental gene expression in severe preeclampsia. Placenta 2009;30:424-433.
26. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-8423.
27. Tsai S, Hardison NE, James AH, Motsinger-Reif AA, Bischoff SR, Thames BH, Piedrahita JA. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta 2011;32:175-182.
28. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 2009;150:52-62.
29. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173-192.